Literature DB >> 28823876

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2-Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues.

Kris M Mahadeo1, Jennifer McArthur2, Roberta H Adams3, Mohamed Radhi4, Joseph Angelo5, Asumthia Jeyapalan6, Kathleen Nicol7, Leon Su8, Hanna Rabi9, Jeffery J Auletta10, Vinita Pai11, Christine N Duncan12, Robert Tamburro13, Christopher C Dvorak14, Rajinder P S Bajwa15.   

Abstract

Even though hepatic veno-occlusive disease (VOD) is a potentially fatal complication of hematopoietic cell transplantation (HCT), there is paucity of research on the management of associated multiorgan dysfunction. To help provide standardized care for the management of these patients, the HCT Subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators and the Supportive Care Committee of the Pediatric Blood and Marrow Transplant Consortium, collaborated to develop evidence-based consensus guidelines. After conducting an extensive literature search, in part 2 of this series we discuss the management of fluids and electrolytes, renal dysfunction; ascites, pleural effusion, and transfusion and coagulopathy issues in patients with VOD. We consider the available evidence using the GRADE criteria.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKI; Ascites; Multiorgan dysfunction; Paracentesis; Pleural effusion; Renal failure; SOS; Thrombocytopenia; VOD

Mesh:

Substances:

Year:  2017        PMID: 28823876     DOI: 10.1016/j.bbmt.2017.08.014

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  1 in total

Review 1.  Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Authors:  Lama Elbahlawan; John Bissler; R Ray Morrison
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.